Results 101 to 110 of about 16,707 (188)

Complement–Eosinophil Crosstalk Links Complement Activation to Fibrin Deposition in Eosinophilic Chronic Rhinosinusitis

open access: yes
Allergy, EarlyView.
Ryo Hasegawa   +18 more
wiley   +1 more source

The Dual Face of Fusobacterium nucleatum in Cancer: Foe, Friend or Both?

open access: yesJournal of Periodontal Research, EarlyView.
Fusobacterium nucleatum has established interactions with cancers in humans. However, contrary to a traditional view that these interactions are uniformly pro‐tumoural, recent evidence suggests a more nuanced role, where contact‐dependent and contact‐independent mechanisms may support either tumour progression or restriction depending on tumour site ...
Anjali Chander   +3 more
wiley   +1 more source

Genetic risk variants implicate impaired maintenance and repair of periodontal tissues as causal for periodontitis—A synthesis of recent findings

open access: yesPeriodontology 2000, EarlyView.
AbstractPeriodontitis is a complex inflammatory disease in which the host genome, in conjunction with extrinsic factors, determines susceptibility and progression. Genetic predisposition is the strongest risk factor in the first decades of life. As people age, chronic exposure to the periodontal microbiome puts a strain on the proper maintenance of ...
Arne S. Schaefer   +4 more
wiley   +1 more source

Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma

open access: yesScientific Reports
Sarcomas (SARC) are a highly heterogeneous cancer type that is prone to recurrence and metastasis. Numerous studies have confirmed that Siglecs are involved in immune signaling and play a key role in regulating immune responses in inflammatory diseases ...
Lili Qi   +4 more
doaj   +1 more source

Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma

open access: yesJournal for ImmunoTherapy of Cancer
Background Siglec-E is an immune checkpoint inhibitory molecule. Expression of Siglec-E on the immune cells has been shown to promote tumor regression.
Yuchen Zhang   +12 more
doaj   +1 more source

Cancer‐associated fibroblast heterogeneity across solid and haematological malignancies: Lessons from colorectal cancer and multiple myeloma

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend CAF origins and plasticity give rise to distinct phenotypes with immunosuppressive functions in colorectal cancer and multiple myeloma. These distinct CAF phenotypes contribute to immunosuppressive tumour microenvironments through ECM remodelling, cytokine signalling and immune regulation.
Hui Mo   +4 more
wiley   +1 more source

Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 4, December 2026.
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang   +16 more
wiley   +1 more source

Siglec Expression Patterns in Food Allergy Reveal Altered Intensity but Not Frequency

open access: yes
Clinical &Experimental Allergy, EarlyView.
J. S. H. Schaapherder   +5 more
wiley   +1 more source

Multi‐Omics Mendelian Randomization Prioritizes Candidate Druggable Genes for Major Depressive Disorder

open access: yesGenes, Brain and Behavior, Volume 25, Issue 6, December 2026.
A multi‐omics Mendelian randomization framework integrating blood and brain eQTL/pQTL data with FinnGen GWAS identified six druggable genes causally associated with major depressive disorder. Colocalization and phenome‐wide analyses supported shared genetic architecture and safety profiles, highlighting immune‐inflammatory pathways as promising ...
Huijing Zhou   +9 more
wiley   +1 more source

Siglec-1 colocalizes with p24 in VCCs of HIV-1-infected MDMs.

open access: yes, 2017
(A) MDMs were infected with a biological stock of HIV-1 BaL at a TCID50 of 0.5/cell. 10 days post-infection cells were fixed and immunolabeled for HIV-1 p24 (green), CD9 (red), tetherin (magenta) and DAPI co-stained. (B) Same immunostaining profile as (A)
Sarah Takushi (3699919)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy